We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$270M
AUM Growth
+$16M
Cap. Flow
+$2.67M
Cap. Flow %
0.99%
Top 10 Hldgs %
18.47%
Holding
276
New
10
Increased
19
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$427K
2
VZ icon
Verizon
VZ
+$325K
3
LLY icon
Eli Lilly
LLY
+$229K
4
EW icon
Edwards Lifesciences
EW
+$213K
5
CTXS
Citrix Systems Inc
CTXS
+$208K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$707K
2
FRX
FOREST LABORATORIES INC
FRX
+$420K
3
WFM
Whole Foods Market Inc
WFM
+$250K
4
NBR icon
Nabors Industries
NBR
+$247K
5
NVDA icon
NVIDIA
NVDA
+$211K

Sector Composition

Rank Sector Weight
1 Technology 16.94%
2 Financials 15.92%
3 Healthcare 14.37%
4 Energy 10.48%
5 Communication Services 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECL icon
76
Ecolab
ECL
$76.8B
$1.03M 0.38%
9,278
– –
MET icon
77
MetLife
MET
$62.1B
$1.02M 0.38%
20,603
– –
LOW icon
78
Lowe's Companies
LOW
$109B
$1.02M 0.38%
21,231
– –
BAX icon
79
Baxter International
BAX
$12B
$1.01M 0.37%
25,665
– –
APA icon
80
APA Corp
APA
$15.8B
$1M 0.37%
9,988
– –
ACN icon
81
Accenture
ACN
$116B
$989K 0.37%
12,232
– –
NBL
82
DELISTED
Noble Energy, Inc.
NBL
$987K 0.37%
12,736
– –
HPQ icon
83
HP
HPQ
$30B
$973K 0.36%
63,640
– –
NKE icon
84
Nike
NKE
$53.1B
$972K 0.36%
25,060
– –
DTV
85
DELISTED
DIRECTV COM STK (DE)
DTV
$970K 0.36%
11,407
– –
WMB icon
86
Williams Companies
WMB
$87.8B
$964K 0.36%
16,567
– –
COST icon
87
Costco
COST
$395B
$960K 0.36%
8,336
+1,710
+26% +$196K
NSC icon
88
Norfolk Southern
NSC
$71.1B
$960K 0.36%
9,319
– –
KRFT
89
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$955K 0.35%
15,926
– –
AMT icon
90
American Tower
AMT
$82.4B
$953K 0.35%
10,594
– –
PXD
91
DELISTED
Pioneer Natural Resource Co.
PXD
$940K 0.35%
4,090
– –
NOV icon
92
NOV
NOV
$7.29B
$937K 0.35%
11,379
-1,240
-10% -$92.4K
LYB icon
93
LyondellBasell Industries
LYB
$20.7B
$919K 0.34%
9,411
– –
KMB icon
94
Kimberly-Clark
KMB
$32.5B
$915K 0.34%
8,583
– –
ESRX
95
DELISTED
Express Scripts Holding Company
ESRX
$910K 0.34%
13,132
– –
MUR icon
96
Murphy Oil
MUR
$5.42B
$906K 0.34%
13,635
– –
TMO icon
97
Thermo Fisher Scientific
TMO
$243B
$906K 0.34%
7,676
– –
TJX icon
98
TJX Companies
TJX
$137B
$886K 0.33%
33,322
– –
TXN icon
99
Texas Instruments
TXN
$236B
$884K 0.33%
18,499
– –
JCI icon
100
Johnson Controls International
JCI
$85.6B
$883K 0.33%
16,882
– –
2 3
4
5 6

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.9B AUM 57.85% 1-Year Est. Return
JPM
JANA Partners Management New York $1.9B AUM 18.33% 1-Year Est. Return
PP
PDT Partners New York $1.9B AUM 71.86% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
DC
Dendur Capital New York $1.9B AUM 46.69% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.9B AUM 14.31% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

Everence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Everence Capital Management held 276 positions worth $270M, up 6.3% from $254M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Everence Capital Management's Q2 2014 filing shows 10 new, 19 increased, 6 reduced and 5 closed positions. Its largest new stake was Edwards Lifesciences: 15,720 shares worth $225K. The largest sale was Celgene Corp, an estimated $707K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Everence Capital Management's largest Q2 2014 buy was Edwards Lifesciences: 15,720 shares worth $225K.
  • Everence Capital Management added most to General Motors in Q2 2014, an estimated $427K increase.
  • Everence Capital Management's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $707K.
  • Everence Capital Management fully exited FOREST LABORATORIES INC in Q2 2014, selling an estimated $420K.
  • Everence Capital Management's ten largest holdings make up 18% of its $270M portfolio in Q2 2014.
  • Everence Capital Management opened 10 new positions and closed 5 in Q2 2014.
  • Everence Capital Management's portfolio value rose 6.3% quarter-over-quarter to $270M.

Based on Everence Capital Management's 13F filing for Q2 2014, filed 4 Aug 2014.